Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
TGTX > SEC Filings for TGTX > Form 8-K on 15-Nov-2012All Recent SEC Filings

Show all filings for TG THERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for TG THERAPEUTICS, INC.


15-Nov-2012

Entry into a Material Definitive Agreement, Change in Directors or Principa


Item 1.01. Entry into a Material Definitive Agreement.

On November 15, 2012, TG Therapeutics, Inc. (the "Company") issued a press release announcing that it had entered into an exclusive licensing agreement (the "Agreement") with Ildong Pharmaceutical Co. Ltd. ("Ildong") for the development and commercialization of the Company's novel anti-CD20 antibody, Ublituximab (TGTX-1101) in South Korea and Southeast Asia. A copy of the press release, which outlines the material terms of the Agreement, is attached as Exhibit 99.1 to this report and is incorporated herein by reference.



Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On November 15, 2012, the Company amended that certain Restricted Stock Subscription Agreement, dated November 15, 2011, by and between the Company and Sean Power (the "Subscription Agreement") to revise the vesting schedule contained therein. Pursuant to the amendment, Mr. Power's 25,000 shares of Company common stock, par value $.001 per share, set to vest on November 15, 2012 will now vest on "the later of November 15, 2012 or the date on which the Company has a 30-day weighted average trading volume in excess of 50,000 for a period of 30 days." All other provisions in the Subscription Agreement remain unchanged.



Item 9.01 Financial Statements And Exhibits.

(d) Exhibits.

99.1 Press release issued by TG Therapeutics, Inc. on November 15, 2012.

- 2 -

  Add TGTX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for TGTX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.